| Eshoo bill huge boon for Silicon Valley biotech - San Francisco Chronicle |
|
|
San Francisco ChronicleEpogen, to treat anemia caused by renal failure, more than $84000; Avastin, a lung cancer drug, $100000; and Cerezyme, to treat Gaucher's disease, ... read more |